Company Filing History:
5 out of 4,671 
3 out of 5,307 
1 out of 1 Years Active: 2019-2024
Title: Innovations of Robert Kaiser in CRISPR Technology
Introduction
Robert Kaiser is a prominent inventor based in Santa Clara, California, known for his significant contributions to the field of genetic engineering. He holds a total of six patents, showcasing his innovative approach to advancing CRISPR technology.
Latest Patents
One of his latest patents is titled "Guide RNAs with chemical modification for prime editing." This invention provides compositions and methods for inducing CRISPR/Cas-based editing of target nucleic acids, such as DNA or RNA, using modified prime editing guide RNAs (pegRNAs) that incorporate chemically-modified nucleotides. These modified pegRNAs can induce Cas-mediated incorporation of nucleotide changes, including insertions or deletions. Another notable patent is "Compositions comprising chemically modified guide RNAs for CRISPR/Cas-mediated editing of HBB." This patent outlines methods for inducing CRISPR/Cas-based gene regulation in cells, enhancing gene regulation of target nucleic acids for potential therapeutic applications.
Career Highlights
Throughout his career, Robert Kaiser has worked with esteemed organizations such as Agilent Technologies, Inc. and Leland Stanford Junior University. His work has significantly impacted the field of genetic research and therapy.
Collaborations
Robert has collaborated with notable colleagues, including Daniel E. Ryan and Douglas J. Dellinger, contributing to advancements in CRISPR technology and its applications.
Conclusion
Robert Kaiser is a key figure in the realm of genetic engineering, with his innovative patents paving the way for future developments in CRISPR technology. His work continues to influence the field and offers promising solutions for genetic diseases.